Boundless Bio IPOs ecDNA Platform
SAN DIEGO – Boundless Bio, Inc. is taking its innovative therapeutics directed against extrachromosomal DNA (ecDNA) – fragments of chromosomes that lead to oncogene amplified cancer – to the boundless…
SAN DIEGO – Boundless Bio, Inc. is taking its innovative therapeutics directed against extrachromosomal DNA (ecDNA) – fragments of chromosomes that lead to oncogene amplified cancer – to the boundless…